Gary Deng

TL;DR: In this article, the authors provided updated clinical practice guidelines from the Society for Integrative Oncology on the use of integrative therapies for specific clinical indications during and after breast cancer treatment, including anxiety/stress, depression/mood disorders, fatigue, quality of life/physical functioning, chemotherapy-induced nausea and vomiting, lymphedema, chemotherapyinduced peripheral neuropathy, pain, and sleep disturbance.

TL;DR: Evidence regarding the efficacy and safety of complementary/alternative medicine (CAM) is reviewed, and implications for oncologists are discussed.

TL;DR: Specific integrative therapies can be recommended as evidence-based supportive care options during breast cancer treatment and require further investigation via well-designed controlled trials with meaningful outcomes.

TL;DR: The authors summarize the research on these modalities and discuss the rationale, expectation, and necessary precautions involved with combining complementary therapies and mainstream care.

TL;DR: Hot flash frequency in breast cancer patients was reduced following acupuncture, however, when compared with sham acupuncture, the reduction by the acupuncture regimen as provided in the current study did not reach statistical significance.